Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma: Abstracted from: Jocham D, Richter A, Hoffmann L et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 2004;363:594–599.

✍ Scribed by Chris Coppin

• Book ID: 116394911
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 234 KB
• Volume: 30
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2004.06.006